The effect of dexmedetomidine on liver histopathology in a rat sepsis model: An experimental pilot study

Ulusal Travma ve Acil Cerrahi Dergisi

Volumn 16, Issue 2, 2010, Pages 108-112

  Sezer, Atakan ^a   Memiş, Dilek ^a   Usta, Ufuk ^a   Süt, Necdet ^a  

^a TRAKYA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Dexmedetomidine; Experimental sepsis; Liver dysfunction

Indexed keywords

DEXMEDETOMIDINE; ENDOTOXIN; LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG EFFECT; ENDOTOXEMIA; ESCHERICHIA COLI; FEMALE; HISTOPATHOLOGY; LIVER DISEASE; LIVER PARENCHYMA; NONHUMAN; RAT; SEPSIS;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; DEXMEDETOMIDINE; ENDOTOXEMIA; ENDOTOXINS; ESCHERICHIA COLI; FEMALE; INFLAMMATION; LIPOPOLYSACCHARIDES; LIVER; RATS; RATS, WISTAR; SEPSIS;

EID: 77649312963     PISSN: 1306696X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Abe Y, Hashimoto S, Horie T. Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacol Res 1999;39:41-7.
2. Diekema DJ, Pfaller MA, Jones RN, Doern GV, Winokur PL, Gales AC, et al. Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997. Clin Infect Dis 1999;29:595-607.
3. Wenzel RP, Pinsky MR, Ulevitch RJ, Young L. Current understanding of sepsis. Clin Infect Dis 1996;22:407-12.
4. Bochud PY, Calandra T. Pathogenesis of sepsis: new concepts and implications for future treatment. BMJ 2003;326:262-6.
5. Su GL. Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation. Am J Physiol Gastrointest Liver Physiol 2002;283:G256-65.
6. Kaur G, Tirkey N, Bharrhan S, Chanana V, Rishi P, Chopra K. Inhibition of oxidative stress and cytokine activity by curcumin in amelioration of endotoxin-induced experimental hepatoxicity in rodents. Clin Exp Immunol 2006;145:313-21.
7. Kono H, Asakawa M, Fujii H, Maki A, Amemiya H, Yamamoto M, et al. Edaravone, a novel free radical scavenger, prevents liver injury and mortality in rats administered endotoxin. J Pharmacol Exp Ther 2003;307:74-82.
8. Matsuda H, Ishikado A, Nishida N, Ninomiya K, Fujiwara H, Kobayashi Y, et al. Hepatoprotective, superoxide scavenging, and antioxidative activities of aromatic constituents from the bark of Betula platyphylla var. japonica. Bioorg Med Chem Lett 1998;8:2939-44.
9. Venn RM, Bradshaw CJ, Spencer R, Brealey D, Caudwell E, Naughton C, et al. Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia 1999;54:1136-42.
10. Virtanen R, Savola JM, Saano V, Nyman L. Characterization of the selectivity, specificity and potency of medetomidine as an alpha 2-adrenoceptor agonist. Eur J Pharmacol 1988;150:9-14.
11. Triltsch AE, Welte M, von Homeyer P, Grosse J, Genähr A, Moshirzadeh M, et al. Bispectral index-guided sedation with dexmedetomidine in intensive care: a prospective, randomized, double blind, placebo-controlled phase II study. Crit Care Med 2002;30:1007-14.
12. Lee JJ, Huang WT, Shao DZ, Liao JF, Lin MT. Blocking NFkappaB activation may be an effective strategy in the fever therapy. Jpn J Physiol 2003;53:367-75.
13. Jobin C, Bradham CA, Russo MP, Juma B, Narula AS, Brenner DA, et al. Curcumin blocks cytokine-mediated NFkappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. J Immunol 1999;163:3474-83.
14. Feng SH, Lo SC. Lipid extract of Mycoplasma penetrans proteinase K-digested lipid-associated membrane proteins rapidly activates NF-kappaB and activator protein 1. Infect Immun 1999;67:2951-6.
15. Franzoso G, Bours V, Park S, Tomita-Yamaguchi M, Kelly K, Siebenlist U. The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kappa B-mediated inhibition. Nature 1992;359:339-42.
16. Wintroub BU. Inflammation and mediators. Int J Dermatol 1980;19:436-42.
17. Till GO, Johnson KJ, Kunkel R, Ward PA. Intravascular activation of complement and acute lung injury. Dependency on neutrophils and toxic oxygen metabolites. J Clin Invest. 1982;69:1126-35.
18. Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wolpe S, Milsark IW, et al. Shock and tissue injury induced by recombinant human cachectin. Science 1986;234:470-4.
19. Straub RH, Herrmann M, Berkmiller G, Frauenholz T, Lang B, Schölmerich J, et al. Neuronal regulation of interleukin 6 secretion in murine spleen: adrenergic and opioidergic control. J Neurochem 1997;68:1633-9.
20. Maes M, Lin A, Kenis G, Egyed B, Bosmans E. The effects of noradrenaline and alpha-2 adrenoceptor agents on the production of monocytic products. Psychiatry Res 2000;96:245-53.
21. Szelényi J, Kiss JP, Vizi ES. Differential involvement of sympathetic nervous system and immune system in the modulation of TNF-alpha production by alpha2- and betaadrenoceptors in mice. J Neuroimmunol 2000;103:34-40.
22. Venn RM, Bryant A, Hall GM, Grounds RM. Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine and inflammatory responses in post-operative patients needing sedation in the intensive care unit. Br J Anaesth 2001;86:650-6.
23. Taniguchi T, Kidani Y, Kanakura H, Takemoto Y, Yamamoto K. Effects of dexmedetomidine on mortality rate and inflammatory responses to endotoxin-induced shock in rats. Crit Care Med 2004;32:1322-6.
24. Memiş D, Hekimoǧlu S, Vatan I, Yandim T, Yüksel M, Süt N. Effects of midazolam and dexmedetomidine on inflammatory responses and gastric intramucosal pH to sepsis, in critically ill patients. Br J Anaesth 2007;98:550-2.